MVIS® US Listed Pharmaceutical 25 Index

The MVIS® US Listed Pharmaceutical 25 Index (MVPPH) tracks the performance of the 25 largest and most liquid US exchange-listed companies in the pharmaceutical industry. This is a modified market cap-weighted index, and only includes companies that generate at least 50% of their revenue from pharmaceutical related products and services, such as research and development, production, or marketing and sales.

Country Weightings

Country weightings are based on the weightings of all index components in a certain country.

CountryComponentsWeight
Canada1 0.77%
United States13 54.53%
Denmark1 5.73%
France1 4.60%
Ireland2 3.80%
Netherlands1 3.26%
Switzerland1 4.99%
United Kingdom3 14.41%
Israel1 3.15%
Japan1 4.76%
Total25 100.00%
SectorComponentsWeight
Consumer Staples1 4.61%
Health Care24 95.39%
Total25 100.00%

Size Weightings

  • Large-Cap: companies with a market capitalisation above 6,000 mln USD
  • Mid-Cap: companies with a market capitalisation from 1,500 mln to 6,000 mln USD
  • Small-Cap: companies with a market capitalisation from 200 mln to 1,500 mln USD
  • Micro-Cap: companies with a market capitalisation up to 200 mln USD
SizeMarket CapComponentsWeight
Large-Cap2,728,714,506,400 USD20 94.72%
Mid-Cap19,994,911,800 USD5 5.28%
Small-Cap---
Micro-Cap---
Total2,748,709,418,200 USD25 100.00%
Up